9 research outputs found

    Valutazione del rischio elettromagnetico ai sensi del D.Lgs. 81/2008 presso l\u27Azienda Ospedaliera Mellino Mellini Chiari (Brescia)

    Get PDF
    .La relazione riferisce i risultati della campagna di misura effettuata nei giorni dal 6 al 9 giugno 2011 e successivamente il 4 e il 6 luglio 2011. La campagna ? stata preceduta da un sopralluogo (21 marzo 2011) alle strutture di competenza dell\u27Azienda Mellino Mellini (Chiari, Iseo, Rovato, Palazzolo ed Orzinuovi) per la definizione delle azioni da intraprendere per la valutazione del rischio elettromagnetico in conformit? al D.Lgs. 81/2008. Pi? specificatamente gli obiettivi della campagna di misura sono stati i seguenti. Misura dei campi elettromagnetici (EM) in punti predefiniti per la determinazione dei livelli di campo EM presenti. Determinazione dei campi elettrici, magnetici ed elettromagnetici emessi da apparecchiature elettromedicali quali magnetoterapia e radarterapia . Misura dei campi magnetici (in particolare induzione magnetica) presenti nei locali tecnici quali cabina elettrica e impianti di condizionamento. Valutazione dell\u27intensit? dell\u27induzione magnetica all\u27interno e in prossimit? di incubatrici e culle termiche (Chiari e Iseo). Valutazione delle specifiche tecniche di elettrobisturi (Blocco Operatorio di Iseo). Caratterizzazione della presenza di eventuali interferenze EM dovute alla rete wireless (reparto di terapia intensiva di cardiologia di Chiari) o da disturbi EM presenti su apparecchiature per diagnostica (neurologia di Chiari)

    Valutazione del rischio elettromagnetico ai sensi del D.Lgs. 81/2008 presso l'Azienda Ospedaliera Mellino Mellini Chiari (Brescia)

    Get PDF
    La relazione riferisce i risultati della campagna di misura effettuata nei giorni dal 6 al 9 giugno 2011 e successivamente il 4 e il 6 luglio 2011. La campagna è stata preceduta da un sopralluogo (21 marzo 2011) alle strutture di competenza dell'Azienda Mellino Mellini (Chiari, Iseo, Rovato, Palazzolo ed Orzinuovi) per la definizione delle azioni da intraprendere per la valutazione del rischio elettromagnetico in conformità al D.Lgs. 81/2008. Più specificatamente gli obiettivi della campagna di misura sono stati i seguenti: 1)Misura dei campi elettromagnetici (EM) in punti predefiniti per la determinazione dei livelli di campo EM presenti. 2)Determinazione dei campi elettrici, magnetici ed elettromagnetici emessi da apparecchiature elettromedicali, tra le quali magnetoterapia e radarterapia . 3)Misura dei campi magnetici (in particolare induzione magnetica) presenti nei locali tecnici quali cabine elettriche e impianti di condizionamento. 4)Valutazione dell'intensità dell'induzione magnetica all'interno e in prossimità di incubatrici. 5)Valutazione delle specifiche tecniche di elettrobisturi. 6)Caratterizzazione della presenza di eventuali interferenze EM dovute alla rete o a disturbi EM presenti su apparecchiature per diagnostica

    [Sensitization against Parietaria pollen in a group of 1143 patients in the Brescian area].

    No full text
    1143 patients were selected among atopic outpatients followed up at our Institution (Clinical Immunology-University of Brescia) on the basis of documented sensitization to one or more inhalant allergens. All patients had been investigated by skin prick tests employing a large panel of allergens. Specific sensitization had been confirmed by clinical history and when necessary by RAST. The patients were investigated retrospectively for the prevalence of sensitization to Paretaria. 880 patients were sensitized to one or more pollens and among these 427 (48.5) to Parietaria. Among pollen monosensitized patients (with no concomitant allergy to other inhalants), 222 were sensitized to Graminacee and 125 to Parietaria. In these groups there was no difference in prevalence of asthma. Our study thereby shows that the prevalence of sensitization to Parietaria in Brescia is higher than described in other cities in North Italy. Our findings are supported by pollen concentration in atmosphere as determined by Burkard pollen trap

    The epidemiological pattern of chronic liver diseases in acommunity undergoing voluntary screening for hepatitis B and C.

    No full text
    Background: Vallecamonica-Sebino is a community in Northern Italy (99,776 inhabitants) with one of the highest mortality rates for primary liver cancer and cirrhosis in Italy, and voluntary screening for HCV and HBV is widespread. The aim of this study was to estimate the prevalence of chronic liver diseases and their aetiology in the area. Methods: We used the following sources of data, linked at an individual level: (1) hospital discharge data; (2) local Viral Hepatitis Services; (3) tests for anti-HCV antibodies and HBsAg from local laboratories; (4) Local Health Authority registry of chronic liver disease patients; (5) drug prescriptions for HBV and HCV treatment; (6) archives of Alcohol Units. Results: 3.5% of the residents had chronic liver disease, mainly chronic hepatitis (61.6%), followed by cirrhosis (14.0%) and alcoholic liver disease (11.2%). HCV was the main cause of chronic liver disease in females (46.3%) and males (29.8%), followed by alcohol abuse in males (22.9%) and HBV (10.9% males and 9.2% females). Prevalence of anti-HCV positivity was 3.2%, and increased with age to 8.8% in subjects aged 65 years and over. Conclusion: This study shows that an epidemiologic pattern of the prevalence of chronic liver diseases and their aetiology can be obtained using routinely collected data

    High prevalence of parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries

    No full text
    OBJECTIVE: To assess the prevalence of Parkinsonian disturbances in relationship to environmental exposure to manganese due to ferroalloy industries in the province of Brescia, Northern Italy. METHODS: Manganese concentrations were measured in settled dust collected in each of the 206 municipalities. Parkinsonian patients were identified using two sources: (1) clinical registers from local hospitals, specialized neurologists, and exemption from prescription payment; (2) L-Dopa prescriptions. Standardized prevalence rates and raw and full Bayesian-smoothed standardized morbidity ratios (SMRs) were calculated for the entire province and for each municipality. RESULTS: Manganese concentrations in settled dust were significantly higher in the surroundings and downwind from the industrial plants. A total number of 2,677 Parkinsonian cases were identified among 903,997 residents (crude prevalence, 296/100,000; 95% CI: 284.80-307.20; standardized prevalence, 407/100,000; 95% CI: 393.87-420.12). Significantly higher SMRs (Kruskal-Wallis chi(2) 1 df = 17.55, P < 0.001) were observed in 37 municipalities in the vicinities of ferromanganese plants (324 cases among 77,708 residents; standardized prevalence 492/100,000; 95% CI: 442.80-541.20), compared to the other 169 municipalities of the province (2,353 cases among 826,289 residents, standardized prevalence 321/100,000; 95% CI 308.80-333.20). Row and Bayesian SMRs were associated with the concentrations of manganese in settled dust. CONCLUSION: Study results suggest that environmental exposure to manganese is associated with an increased prevalence of Parkinsonian disturbances. Since the highest prevalence rates were observed in a closed community of the pre-Alps where the industries are located, further research should address a possible interactive role of genetic factors
    corecore